Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Histopathologic Evolution of Melanocytes Associated With Rapid Clinical Progression of Melanoma: Clinicopathologic Presentation of Hyperprogressive Disease in a Patient Treated With Immunotherapy.
Journal: The American Journal of dermatopathology
Published: November 17, 2022
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimen.
Journal: Medical oncology (Northwood, London, England)
Published: December 06, 2021
Development of carpal tunnel syndrome in association with checkpoint inhibitors.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: August 21, 2020
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.
Journal: British journal of cancer
Published: December 31, 2018
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 12, 2018
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1.
Journal: Cancer immunology, immunotherapy : CII
Published: January 29, 2018
Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: December 22, 2017
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 25, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 29, 2017
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 30, 2016
Last Updated: 09/26/2026